95044

Patch or application test(s) (specify number of tests)

CPT code 95044 represents the administration of patch or application tests to identify specific substances (allergens) that are causing delayed-type hypersensitivity reactions, commonly known as allergic contact dermatitis. This diagnostic procedure is fundamentally different from immediate hypersensitivity prick or scratch testing (which evaluates IgE-mediated reactions), as patch testing assesses cell-mediated (Type IV) allergic responses that typically develop over several days. During this procedure, the physician or qualified healthcare professional selects a panel of suspected allergens based on the patient's comprehensive clinical history, occupational exposures, hobbies, and the anatomical distribution of the current skin rash. The selected allergens—often including metals like nickel and cobalt, preservatives, fragrances, rubber accelerators, and topical medications—are prepared in appropriate concentrations and vehicles. They are placed into small chambers (such as Finn chambers or pre-prepared systems like the T.R.U.E. test) and secured directly to the patient's unaltered skin, most commonly on the upper back, using hypoallergenic adhesive tape. The application process requires precise placement and mapping of each substance to ensure accurate identification during subsequent readings. Patients are given strict instructions to keep the test area completely dry, avoid excessive sweating, and refrain from taking immunosuppressive medications or systemic corticosteroids that could suppress a localized reaction. After an initial period of 48 hours, the patient returns to the clinic where the patches are carefully removed. The physician performs an initial reading to evaluate the skin for erythema, induration, papules, or vesicles corresponding to each test site. Because many contact allergens require more time to elicit a visible immune response, a crucial secondary reading is typically performed at 72 to 96 hours after the initial application, and occasionally up to one week later. The severity of the reaction is graded and documented, allowing the physician to synthesize the diagnostic data, definitively identify the offending agents, and formulate a targeted avoidance and management plan for the patient's dermatological condition.

Clinical Indications

  • Suspected allergic contact dermatitis
  • Chronic or atypical eczema failing to respond to conventional therapies
  • Occupational dermatoses requiring identification of workplace allergens
  • Evaluation of suspected hypersensitivity to cosmetics, fragrances, and personal care products
  • Reactions suspected to be caused by medical devices, dental materials, or orthopedic implants
  • Erythroderma or widespread dermatitis of unknown etiology

Procedure Steps

  1. Review the patient's clinical history and specific environmental or occupational exposures to select appropriate allergens.
  2. Prepare the testing chambers by dispensing the customized allergens or utilizing standardized pre-packaged allergen panels.
  3. Cleanse and prepare the skin on the patient's back, ensuring it is free of current active dermatitis.
  4. Apply the patches to the back, map the exact location of each allergen using a specialized template, and secure them with hypoallergenic adhesive.
  5. Counsel the patient on test maintenance, including avoiding water exposure to the back and minimizing physical exertion for 48 hours.
  6. Remove the patches after 48 hours and perform the initial reading to assess for early signs of erythema or induration.
  7. Conduct the delayed, definitive reading at 72 to 96 hours (or later) to grade and interpret cell-mediated hypersensitivity reactions.
  8. Synthesize the reading results, document the identified allergens, and provide customized avoidance education to the patient.

Coding Guidelines

  • Bill CPT 95044 in units corresponding to the exact number of individual patches/allergens applied, not as a single global procedure code.
  • The code encompasses both the initial application of the patches and all subsequent readings; do not bill separate E/M codes solely for the readings.
  • If a significant, separately identifiable Evaluation and Management (E/M) service is provided on the day of application, it may be reported with modifier 25.
  • Pre-packaged tests, such as the T.R.U.E. test, typically contain a specific number of allergens (e.g., 35 or 36); bill the exact number of substances tested.
  • Do not confuse patch testing (95044) with percutaneous/scratch testing (95004) or intracutaneous testing (95024), which are for immediate IgE-mediated allergies.
  • Ensure documentation clearly lists the individual allergens tested, the clinical rationale, and the graded results of all readings.

Associated ICD-10 Codes